Literature DB >> 9456264

HIV-1 RNA detectable with ultrasensitive quantitative polymerase chain reaction in plasma but not in cerebrospinal fluid during combination treatment with zidovudine, lamivudine and indinavir.

M Gisslén, G Norkrans, B Svennerholm, L Hagberg.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9456264

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  6 in total

1.  Diffusion tensor imaging of patients with HIV and normal-appearing white matter on MR images of the brain.

Authors:  C G Filippi; A M Ulug; E Ryan; S J Ferrando; W van Gorp
Journal:  AJNR Am J Neuroradiol       Date:  2001-02       Impact factor: 3.825

Review 2.  Neurologic aspects of HIV infection in infants and children: therapeutic approaches and outcome.

Authors:  Lucy Civitello
Journal:  Curr Neurol Neurosci Rep       Date:  2003-03       Impact factor: 5.081

Review 3.  Pharmacokinetics and pharmacodynamics of antiretrovirals in the central nervous system.

Authors:  Andrea Calcagno; Giovanni Di Perri; Stefano Bonora
Journal:  Clin Pharmacokinet       Date:  2014-10       Impact factor: 6.447

Review 4.  Clinical implications of CNS penetration of antiretroviral drugs.

Authors:  Heather E Wynn; Richard C Brundage; Courtney V Fletcher
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

5.  Cerebrospinal fluid HIV-1 RNA, intrathecal immunoactivation, and drug concentrations after treatment with a combination of saquinavir, nelfinavir, and two nucleoside analogues: the M61022 study.

Authors:  Aylin Yilmaz; Dietmar Fuchs; Lars Hagberg; Ulrika Nillroth; Lars Ståhle; Jan-Olof Svensson; Magnus Gisslén
Journal:  BMC Infect Dis       Date:  2006-03-27       Impact factor: 3.090

6.  Effect of antiretroviral treatment on blood-brain barrier integrity in HIV-1 infection.

Authors:  Birgitta Anesten; Henrik Zetterberg; Staffan Nilsson; Bruce J Brew; Dietmar Fuchs; Richard W Price; Magnus Gisslén; Aylin Yilmaz
Journal:  BMC Neurol       Date:  2021-12-22       Impact factor: 2.474

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.